These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 26756900)

  • 21. Resveratrol causes COX-2- and p53-dependent apoptosis in head and neck squamous cell cancer cells.
    Lin HY; Sun M; Tang HY; Simone TM; Wu YH; Grandis JR; Cao HJ; Davis PJ; Davis FB
    J Cell Biochem; 2008 Aug; 104(6):2131-42. PubMed ID: 18446786
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Doxorubicin induces expression of multidrug resistance-associated protein 1 in human small cell lung cancer cell lines by the c-jun N-terminal kinase pathway.
    Shinoda C; Maruyama M; Fujishita T; Dohkan J; Oda H; Shinoda K; Yamada T; Miyabayashi K; Hayashi R; Kawagishi Y; Fujita T; Matsui S; Sugiyama E; Muraguchi A; Kobayashi M
    Int J Cancer; 2005 Oct; 117(1):21-31. PubMed ID: 15880572
    [TBL] [Abstract][Full Text] [Related]  

  • 23. COX-2 inhibitors suppress integrin alpha5 expression in human lung carcinoma cells through activation of Erk: involvement of Sp1 and AP-1 sites.
    Han S; Roman J
    Int J Cancer; 2005 Sep; 116(4):536-46. PubMed ID: 15825163
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Celecoxib enhances doxorubicin-induced cytotoxicity in MDA-MB231 cells by NF-kappaB-mediated increase of intracellular doxorubicin accumulation.
    van Wijngaarden J; van Beek E; van Rossum G; van der Bent C; Hoekman K; van der Pluijm G; van der Pol MA; Broxterman HJ; van Hinsbergh VW; Löwik CW
    Eur J Cancer; 2007 Jan; 43(2):433-42. PubMed ID: 17097285
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ER-Dependent Ca++-mediated Cytosolic ROS as an Effector for Induction of Mitochondrial Apoptotic and ATM-JNK Signal Pathways in Gallic Acid-treated Human Oral Cancer Cells.
    Lu YC; Lin ML; Su HL; Chen SS
    Anticancer Res; 2016 Feb; 36(2):697-705. PubMed ID: 26851027
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Proton induces apoptosis of hypoxic tumor cells by the p53-dependent and p38/JNK MAPK signaling pathways.
    Lee KB; Kim KR; Huh TL; Lee YM
    Int J Oncol; 2008 Dec; 33(6):1247-56. PubMed ID: 19020758
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Azacytidine-induced Chemosensitivity to Doxorubicin in Human Breast Cancer MCF7 Cells.
    Khan GN; Kim EJ; Shin TS; Lee SH
    Anticancer Res; 2017 May; 37(5):2355-2364. PubMed ID: 28476801
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stanniocalcin-1 Protects a Mouse Model from Renal Ischemia-Reperfusion Injury by Affecting ROS-Mediated Multiple Signaling Pathways.
    Liu D; Shang H; Liu Y
    Int J Mol Sci; 2016 Jul; 17(7):. PubMed ID: 27420048
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Overcoming the radioresistance of prostate cancer cells with a novel Bcl-2 inhibitor.
    An J; Chervin AS; Nie A; Ducoff HS; Huang Z
    Oncogene; 2007 Feb; 26(5):652-61. PubMed ID: 16909121
    [TBL] [Abstract][Full Text] [Related]  

  • 30. mTOR inactivation by ROS-JNK-p53 pathway plays an essential role in psedolaric acid B induced autophagy-dependent senescence in murine fibrosarcoma L929 cells.
    Qi M; Zhou H; Fan S; Li Z; Yao G; Tashiro S; Onodera S; Xia M; Ikejima T
    Eur J Pharmacol; 2013 Sep; 715(1-3):76-88. PubMed ID: 23810968
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of basal activity of c-jun-NH2-terminal kinase (JNK) represses the expression of presenilin-1 by a p53-dependent mechanism.
    Lee S; Das HK
    Brain Res; 2008 May; 1207():19-31. PubMed ID: 18374905
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Doxorubicin coupled to penetratin promotes apoptosis in CHO cells by a mechanism involving c-Jun NH2-terminal kinase.
    Aroui S; Mili D; Brahim S; De Waard M; Kenani A
    Biochem Biophys Res Commun; 2010 Jun; 396(4):908-14. PubMed ID: 20457128
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The cyclooxygenase-2 inhibitor NS-398 inhibits proliferation and induces apoptosis in human osteosarcoma cells via downregulation of the survivin pathway.
    Duan DP; Dang XQ; Wang KZ; Wang YP; Zhang H; You WL
    Oncol Rep; 2012 Nov; 28(5):1693-700. PubMed ID: 22922684
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of COX-2 in colon cancer cell lines by celecoxib increases the nuclear localization of active p53.
    Swamy MV; Herzog CR; Rao CV
    Cancer Res; 2003 Sep; 63(17):5239-42. PubMed ID: 14500353
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mycotoxin zearalenone induces AIF- and ROS-mediated cell death through p53- and MAPK-dependent signaling pathways in RAW264.7 macrophages.
    Yu JY; Zheng ZH; Son YO; Shi X; Jang YO; Lee JC
    Toxicol In Vitro; 2011 Dec; 25(8):1654-63. PubMed ID: 21767629
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pifithrin-alpha promotes p53-mediated apoptosis in JB6 cells.
    Kaji A; Zhang Y; Nomura M; Bode AM; Ma WY; She QB; Dong Z
    Mol Carcinog; 2003 Jul; 37(3):138-48. PubMed ID: 12884365
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The hierarchical relationship between MAPK signaling and ROS generation in human leukemia cells undergoing apoptosis in response to the proteasome inhibitor Bortezomib.
    Yu C; Rahmani M; Dent P; Grant S
    Exp Cell Res; 2004 May; 295(2):555-66. PubMed ID: 15093752
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Disulfiram/copper complex activated JNK/c-jun pathway and sensitized cytotoxicity of doxorubicin in doxorubicin resistant leukemia HL60 cells.
    Xu B; Shi P; Fombon IS; Zhang Y; Huang F; Wang W; Zhou S
    Blood Cells Mol Dis; 2011 Dec; 47(4):264-9. PubMed ID: 21911303
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulation of Myc-dependent apoptosis by p53, c-Jun N-terminal kinases/stress-activated protein kinases, and Mdm-2.
    Yu K; Ravera CP; Chen YN; McMahon G
    Cell Growth Differ; 1997 Jul; 8(7):731-42. PubMed ID: 9218867
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cyclooxygenase-2 inhibitors prevent the development of chemoresistance phenotype in a breast cancer cell line by inhibiting glycoprotein p-170 expression.
    Zatelli MC; Luchin A; Tagliati F; Leoni S; Piccin D; Bondanelli M; Rossi R; degli Uberti EC
    Endocr Relat Cancer; 2007 Dec; 14(4):1029-38. PubMed ID: 18045954
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.